Chronic Heart Failure (CHF) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

2/1/2012 12:00:00 AM

Individuals suffering from Chronic Heart Failure (CHF) can look forward to the appearance of many new drug options over the next few years, and place hope in a cure through future stem cell therapies. Dissatisfaction with limited CHF therapies, alongside the fast expanding patient population, assures sky-high revenue for pharmaceutical companies willing to develop superior treatments. As a result, numerous molecules are being developed for CHF patients

Archives

GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved